BlackRock Investment Management’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$9K Hold
578
﹤0.01% 3630
2016
Q3
$13K Buy
578
+231
+67% +$5.32K ﹤0.01% 3504
2016
Q2
$6K Sell
347
-7,091
-95% -$189K ﹤0.01% 3822
2016
Q1
$195K Buy
7,438
+146
+2% +$4.55K ﹤0.01% 3164
2015
Q4
$265K Sell
7,292
-13
-0.2% -$564 ﹤0.01% 3179
2015
Q3
$242K Sell
7,305
-154
-2% -$8.67K ﹤0.01% 3209
2015
Q2
$516K Buy
7,459
+2,411
+48% +$166K ﹤0.01% 3112
2015
Q1
$379K Buy
5,048
+75
+2% +$5.9K ﹤0.01% 3065
2014
Q4
$413K Sell
4,973
-27
-0.5% -$2.19K ﹤0.01% 3093
2014
Q3
$407K Sell
5,000
-23
-0.5% -$1.97K ﹤0.01% 3080
2014
Q2
$451K Buy
5,023
+1,902
+61% +$169K ﹤0.01% 3091
2014
Q1
$369K Sell
3,121
-79
-2% -$7.67K ﹤0.01% 3096
2013
Q4
$226K Hold
3,200
﹤0.01% 3205
2013
Q3
$180K Buy
3,200
+285
+10% +$17.9K ﹤0.01% 3199
2013
Q2
$213K Buy
+2,915
New +$168K ﹤0.01% 3153

Other funds holding ALIM

BlackRock Investment Management's ALIM Position: Q4 2016 in Review

BlackRock Investment Management held its Alimera Sciences (ALIM) position steady in Q4 2016 at 578 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #3630.

BlackRock Investment Management first reported a position in ALIM in Q2 2013 and has held it in 15 quarters since. The position peaked at $516K in Q2 2015. 47 funds tracked by Wall St. Rank hold ALIM as of Q4 2016.

  • BlackRock Investment Management held 578 shares of Alimera Sciences worth $9K as of Q4 2016.
  • BlackRock Investment Management left its Alimera Sciences share count unchanged in Q4 2016.
  • Alimera Sciences made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3630 holding.
  • BlackRock Investment Management first reported a position in Alimera Sciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Alimera Sciences position peaked at $516K in Q2 2015.
  • 47 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.